1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  1. Compliance Actions and Activities

Warning Letters

Learn about the types of warning letters on FDA's website.

  • Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.
  • To obtain additional available information, contact FDA. Requests to FDA for agency records should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5630 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found at How to Make a FOIA Request.
  • Frequently requested records may be accessed on the Reading Room page.

 


Posted Date Letter Issue Date Company Name Issuing Office Subject Response Letter Closeout Letter Excerpt
Foshan Miwei Cosmetics Co., Ltd. Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated
Lexia LLC Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated
Intas Pharmaceuticals Limited Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated
Nupack Inc. Human Foods Program CGMP/Dietary Supplement/Adulterated/Misbranded
The Wilatta Group Inc. Office of Inspections and Investigations Foreign Supplier Verification Program (FSVP)
Daily Manufacturing Solutions Inc. Center for Tobacco Products Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated
Thrive Health and Wellness, LLC dba Thrive Health Solutions Center for Drug Evaluation and Research (CDER) Compounding Pharmacy/Adulterated Drug Products
shopcalismokes.com Center for Tobacco Products Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Par Health USA, LLC & Endo USA, Inc. Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated

SUBSCRIBE

Get regular FDA email updates delivered on this topic to your inbox.
Back to Top